Wasatch Advisors Inc Standard Biotools Inc. Transaction History

Wasatch Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 02, 2018	SELL	$5.75 - $7.97 $1.27 Million - $1.77 Million	-221,531 Closed	0 $0
Q4 2017 Jan 16, 2018	SELL	$4.46 - $6.45 $139,861 - $202,265	-31,359 Reduced 12.4%	221,531 $0
Q3 2017 Nov 08, 2017	SELL	$3.55 - $5.49 $231,144 - $357,459	-65,111 Reduced 20.48%	252,890 $0
Q2 2017 Aug 16, 2017	BUY	N/A	318,001	318,001 $0

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $128M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.